# NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients

> **NCT05133791** · PHASE1 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 16 (estimated)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DRUG:** Annexin A5

## Key facts

- **NCT ID:** NCT05133791
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-23
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133791, "NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05133791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*